FDA Inspection 1293934 — Zhejiang Dayang Biotech Group Co. Ltd.
The FDA completed an inspection of Zhejiang Dayang Biotech Group Co. Ltd. on November 20, 2025 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 20, 2025
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Hangzhou (China)